Global gRNA Market Expected to Reach USD 2303.70 Million by 2032, Fueled by CRISPR-Cas9 Adoption and Growing Genomic Research Investments | SNS Insider
September 03, 2024 09:18 ET
|
SNS Insider pvt ltd
Pune, Sept. 03, 2024 (GLOBE NEWSWIRE) -- gRNA Market Size & Growth Analysis: “According to SNS Insider, The gRNA Market Size was valued at USD 498.30 Million in 2023 and is expected to reach...
CRISPR Gene Editing Market Size is projected to reach USD 14.80 Billion by 2030, growing at a CAGR of 29.80%: Straits Research
August 01, 2022 12:40 ET
|
Straits Research
New York, United States, Aug. 01, 2022 (GLOBE NEWSWIRE) -- CRISPR Gene Editing, also called genome editing, modifies an organism's DNA. This method replaces, adds, or removes genetic material from...
CRISPR Therapies Pipeline Insights 2021: Analysis of Key Companies, Emerging Therapies, Recent Happenings and Futuristic Trends
April 12, 2021 20:30 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, April 12, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapies Pipeline Insights 2021: Analysis of Key Companies, Emerging Therapies, Recent Happenings and Futuristic Trends The leading...
Taconic Biosciences Sponsors Custom Model to Support Kabuki Syndrome, a Rare Disorder Causing Intellectual Disability
August 31, 2017 17:21 ET
|
Taconic Biosciences
HUDSON, N.Y., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered rodent models and associated services, is funding the development of a custom mouse...
Taconic Biosciences Announces Partnership With Cergentis B.V. to Provide Transgene Mapping Services
August 08, 2017 16:43 ET
|
Taconic Biosciences
HUDSON, N.Y., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a collaborative agreement...
Taconic Biosciences Secures CRISPR License From ERS Genomics
May 30, 2017 12:20 ET
|
Taconic Biosciences
HUDSON, N.Y., May 30, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a license agreement with...